University of California, San Francisco
San Francisco, California, 94143, United States
Location status: Recruiting
Location contact
Jessica Alway
CONTACT
Maya Vijayaraghavan, MD
CONTACT
NCT Number: NCT07148232
This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 4
San Francisco, California, 94143, United States
Location status: Recruiting
Jessica Alway
CONTACT
Maya Vijayaraghavan, MD
CONTACT
PRIMARY OBJECTIVES:
I. Biochemically verified 7-day point prevalence tobacco abstinence at 6-months follow-up.
II. Use expired carbon monoxide (CO) to confirm self-reports of abstinence using a cut-off of CO ≤5 parts per million (ppm).
SECONDARY OBJECTIVES:
I. Biochemically-verified 7-day point prevalence tobacco abstinence at 3-months follow-up.
II. Measured at 6-months follow-up, a total number of expired carbon monoxide (CO-negative samples).
III. Measured at 6-months follow-up, longest duration of abstinence (i.e., total number of uninterrupted days abstinent), proportion with 50% reduction in expired CO for those who do not quit smoking.
IV. Use expired CO to confirm self-reports of abstinence using a cut-off of CO ≤5 ppm.
OUTLINE:
Participants will be randomized to one of two groups:
Participants will be followed up at 1, 3 and 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NRT will be administered as patch (transdermal), gum, or lozenge
Other names: NRT
Delivered via phone call
Time frame: up to 6 months
The percentage of participants who attended at least 75% or 7 of the 14 coaching sessions will be reported.
Time frame: up to 6 months
The percentage of participants who used at least 75% will adhere to using NRT for at least half of the treatment duration will be reported.
Time frame: 6 months
Biochemically verified 7-day point prevalence tobacco abstinence at 6-months follow-up will be reported.
Time frame: 3 months
Biochemically verified 7-day point prevalence tobacco abstinence at 3-months follow-up will be reported.
Contact information is provided by the study sponsor or research team.
University of California, San Francisco
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01570595
Acquired Immunodeficiency Syndrome, Behavior
The Bronx, New York, United States
View Trial DetailsNCT06609369
Behavior, Dyssomnias
New Haven, Connecticut, United States
View Trial DetailsNCT05429892
Behavior, Chemically-Induced Disorders
Little Rock, Arkansas, United States
View Trial DetailsNCT05415371
Behavior, Contingency Management
Oklahoma City, Oklahoma, United States
View Trial Details